CAN-FITE BIOPHARMA ADR 30
CAN-FITE BIOPHARMA ADR 30
Depository Receipt · US13471N2018 · A2PJNP (XASE)
Overview
No Price
n/a
AI Analysis of CAN-FITE BIOPHARMA ADR 30
Click any analysis below to get instant AI insights from finAgent
Latest AI Analyses of CAN-FITE BIOPHARMA ADR 30
No AI threads available for this company yet.

Company Data

Name CAN-FITE BIOPHARMA ADR 30
Primary Exchange XASE AMEX
WKN A2PJNP
ISIN US13471N2018
Asset Class Depository Receipt
Currency USD

Stock Splits

Date Split
09.01.2023 1:10
10.05.2019 1:15
More Shares
Investors who hold CAN-FITE BIOPHARMA ADR 30 also have the following shares in their portfolio:
AUSTRALIA & NEW ZEALAND BANKING GROUP LD ZERO CPN NTS 15/11/43
AUSTRALIA & NEW ZEALAND BANKING GROUP LD ZERO CPN NTS 15/11/43 Bond
BCO SANTAND. 20/30 MTN
BCO SANTAND. 20/30 MTN Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026